Status:

RECRUITING

Head dOwn Position Before Endovascular Treatment for Large veSsel Occlusion (HOPES5)

Lead Sponsor:

General Hospital of Shenyang Military Region

Conditions:

Ischemic Stroke

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Recent studies suggest that head-down positioning (HDP) intervention may improve outcomes in ischemic stroke. In the era of reperfusion therapy, a key protective strategy is to administer neuroprotect...

Eligibility Criteria

Inclusion

  • Age ≥ 18 years;
  • Patients with acute large vessel occlusion scheduled for endovascular thrombectomy within 24 hours of symptom onset;
  • Baseline National Institute of Health Stroke Scale (NIHSS) ≥ 6;
  • Expected waiting time from randomization to femoral artery puncture is more than 30 minutes;
  • ASPECTS/pc-ASPECTS score ≥ 6 on baseline non-contrast CT or DWI;
  • Modified Rankin Scale score before stroke onset ≤ 1;
  • Signed informed consent by patient or their legally authorized representative.

Exclusion

  • Hemorrhagic stroke: cerebral hemorrhage, subarachnoid hemorrhage;
  • Severe hepatic or renal dysfunction, increase in ALT or AST (more than 2 times of upper limit of normal value), increase in serum creatinine (more than 1.5 times of upper limit of normal value) or requiring dialysis;
  • Severe hypertension before randomization (systolic blood pressure \>185 mmHg or diastolic blood pressure \>110 mmHg);
  • Cardiac insufficiency (NYHA Class ≥II);
  • Pregnancy, plan to get pregnant or during lactation;
  • Patients at significant risk of aspiration (e.g., obvious nausea and vomiting);
  • The estimated life expectancy is less than 6 months due to other serious diseases;
  • Other conditions unsuitable for this clinical study assessed by researcher.

Key Trial Info

Start Date :

September 2 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 30 2026

Estimated Enrollment :

210 Patients enrolled

Trial Details

Trial ID

NCT07172789

Start Date

September 2 2025

End Date

September 30 2026

Last Update

September 15 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hui-Sheng Chen

Shenyang, None Selected, China, 110016